On the public citation graph
Lyngbyastatin 4, a Dolastatin 13 Analogue with Elastase and Chymotrypsin Inhibitory Activity from the Marine Cyanobacterium Lyngbya confervoides
0 signed · 120 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1016/0040-4020(95)00857-8openalex-snapshot
A90720A, a serine protease inhibitor isolated from a terrestrial blue-green alga Microchaete loktakensis
inferredcites →https://doi.org/10.1016/j.chembiol.2003.10.001openalex-snapshot
Binding Structure of Elastase Inhibitor Scyptolin A
inferredcites →https://doi.org/10.1016/s0031-9422(01)00400-9openalex-snapshot
Scyptolin A and B, cyclic depsipeptides from axenic cultures of Scytonema hofmanni PCC 7110
inferredcites →https://doi.org/10.1016/s0040-4020(01)00141-7openalex-snapshot
Protease inhibitors from a water bloom of the cyanobacterium Microcystis aeruginosa
inferredcites →https://doi.org/10.1016/s0040-4020(99)00341-5openalex-snapshot
Oscillapeptins A to F, serine protease inhibitors from the three strains of Oscillatoria agardhii
inferredcites →https://doi.org/10.1021/ja00195a085openalex-snapshot
Molecular and electronic structure of electron-transfer active main-group organometallics [Erratum to document cited in CA110(15):135328y]
inferredcites →https://doi.org/10.1021/ja972991vopenalex-snapshot
Atomic Structure of the Trypsin−Aeruginosin 98-B Complex
inferredcites →https://doi.org/10.1021/jo061044eopenalex-snapshot
Largamides A−H, Unusual Cyclic Peptides from the Marine Cyanobacterium Oscillatoria sp.
inferredcites →https://doi.org/10.1021/np000120kopenalex-snapshot
New Anabaenopeptins, Potent Carboxypeptidase-A Inhibitors from the Cyanobacterium Aphanizomenon flos-aquae
inferredcites →https://doi.org/10.1021/np0005356openalex-snapshot
Isolation of New Protein Phosphatase Inhibitors from Two Cyanobacteria Species, Planktothrix spp.
inferredcites →https://doi.org/10.1021/np010597bopenalex-snapshot
Three Novel Protease Inhibitors from a Natural Bloom of the Cyanobacterium Microcystis aeruginosa
inferredcites →https://doi.org/10.1021/np0401361openalex-snapshot
Two New Chymotrypsin Inhibitors Isolated from the Cyanobacterium Microcystis aeruginosa NIES-88
inferredcites →https://doi.org/10.1021/np9600210openalex-snapshot
Oscillapeptin G, a Tyrosinase Inhibitor from Toxic Oscillatoria agardhii
inferredcites →https://doi.org/10.1038/nrd2092openalex-snapshot
Targeting proteases: successes, failures and future prospects
inferredcites →https://doi.org/10.2174/0929867023369051openalex-snapshot
The Cyanobacterial Origin of Potent Anticancer Agents Originally Isolated from Sea Hares
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.5252/cryptogamie-algologie2021v42a15zenodo-depositor-declared
First Report of Diversity of Cyanobacteria of Broknes Peninsula of Larsemann Hills, East Antarctica
inferred← citeshttps://doi.org/10.1002/9781118500354.ch12openalex-snapshot
Microalgae as a source of nutraceuticals
inferred← citeshttps://doi.org/10.1002/9781119143802.ch61openalex-snapshot
Bioactive Proteins and Peptides from Microalgae
inferred← citeshttps://doi.org/10.1002/9783527805921.ch2openalex-snapshot
Molecular Targets of Clinically Relevant Natural Products from Filamentous Marine Cyanobacteria
inferred← citeshttps://doi.org/10.1002/chem.201203667openalex-snapshot
Total Synthesis and Biological Evaluation of Grassypeptolide A
inferred← citeshttps://doi.org/10.1002/jat.1717openalex-snapshot
A review of pharmacological and toxicological potentials of marine cyanobacterial metabolites
inferred← citeshttps://doi.org/10.1002/jobm.202100459openalex-snapshot
Cyanobacteria derived compounds: Emerging drugs for cancer management
inferred← citeshttps://doi.org/10.1002/med.20247openalex-snapshot
Targeting COPD: advances on low‐molecular‐weight inhibitors of human neutrophil elastase
inferred← citeshttps://doi.org/10.1007/978-3-030-21309-1_39openalex-snapshot
Marine Bioresources—Animals and Veterinary Applications
inferred← citeshttps://doi.org/10.1007/978-3-319-07145-9_29openalex-snapshot
Marine Cyanobacteria Compounds with Anticancer Properties: Implication of Apoptosis
inferred← citeshttps://doi.org/10.1007/978-3-642-36202-6_196-1openalex-snapshot
Lipopeptides Derived from Lower Organisms: Biological Functions and Fatty Acid Integration
inferred← citeshttps://doi.org/10.1007/s00210-023-02488-4openalex-snapshot
Recent progression on phytochemicals and pharmacological properties of the filamentous cyanobacterium Lyngbya sp.
inferred← citeshttps://doi.org/10.1007/s00210-023-02719-8openalex-snapshot
Nanosynthesis, phycochemical constituents, and pharmacological properties of cyanobacterium Oscillatoria sp.
inferred← citeshttps://doi.org/10.1007/s00726-014-1846-4openalex-snapshot
α,β-Dehydroamino acids in naturally occurring peptides
inferred← citeshttps://doi.org/10.1007/s10482-015-0487-2openalex-snapshot
Anticancer compounds from cyanobacterium Lyngbya species: a review
inferred← citeshttps://doi.org/10.1007/s10750-020-04286-yopenalex-snapshot
Natural and anthropogenic dispersal of cyanobacteria: a review
inferred← citeshttps://doi.org/10.1007/s10811-010-9506-xopenalex-snapshot
Filamentous tropical marine cyanobacteria: a rich source of natural products for anticancer drug discovery
inferred← citeshttps://doi.org/10.1007/s11010-021-04306-yopenalex-snapshot
Therapeutic potential of marine peptides in cervical and ovarian cancers
inferred← citeshttps://doi.org/10.1007/s40071-014-0081-7openalex-snapshot
Is production of protease inhibitors from cyanobacteria nutrient dependent? Comparison of protease inhibitory activities in three species of Oscillatoria isolated from Central India
inferred← citeshttps://doi.org/10.1016/b978-0-12-819311-2.00024-3openalex-snapshot
Cyanobacteria: a potential source of anticancer drugs
inferred← citeshttps://doi.org/10.1016/b978-0-12-819483-6.00010-2openalex-snapshot
Cyanobacterial peptides with respect to anticancer activity: Structural and functional perspective
inferred← citeshttps://doi.org/10.1016/b978-0-323-91202-0.00009-9openalex-snapshot
Bioactive compounds and pigments from cyanobacteria: Applications in the pharmaceutical industry
inferred← citeshttps://doi.org/10.1016/b978-0-444-53836-9.00021-9openalex-snapshot
Marine Cyanobacteria
inferred← citeshttps://doi.org/10.1016/j.biotechadv.2009.04.009openalex-snapshot
Biotechnological and industrial significance of cyanobacterial secondary metabolites
inferred← citeshttps://doi.org/10.1016/j.bmc.2020.115756openalex-snapshot
Ahp-Cyclodepsipeptides as tunable inhibitors of human neutrophil elastase and kallikrein 7: Total synthesis of tutuilamide A, serine protease selectivity profile and comparison with lyngbyastatin 7
inferred← citeshttps://doi.org/10.1016/j.cbpc.2010.08.008openalex-snapshot
Marine pharmacology in 2007–8: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms of action
inferred← citeshttps://doi.org/10.1016/j.crbiot.2023.100167openalex-snapshot
Dolastatins and their analogues present a compelling landscape of potential natural and synthetic anticancer drug candidates
inferred← citeshttps://doi.org/10.1016/j.hal.2008.02.004openalex-snapshot
Grazer interactions with four species of Lyngbya in southeast Florida
inferred← citeshttps://doi.org/10.1016/j.hal.2018.11.008openalex-snapshot
Cyanobacterial bioactive metabolites—A review of their chemistry and biology
inferred← citeshttps://doi.org/10.1016/j.hal.2019.05.001openalex-snapshot
Cyanobacterial bioactive metabolites—A review of their chemistry and biology
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2020.12.134openalex-snapshot
A critical review on marine serine protease and its inhibitors: A new wave of drugs?
inferred← citeshttps://doi.org/10.1016/j.ijpddr.2024.100530openalex-snapshot
Modified peptides and organic metabolites of cyanobacterial origin with antiplasmodial properties
inferred← citeshttps://doi.org/10.1016/j.medidd.2026.100259openalex-snapshot
Cyanobacterial peptides and polyketides: biosynthetic basis, structural diversity and therapeutic relevance
inferred← citeshttps://doi.org/10.1016/j.oceano.2017.11.003openalex-snapshot
Bioactive metabolites produced by Spirulina subsalsa from the Baltic Sea
inferred← citeshttps://doi.org/10.1016/j.phrs.2021.105521openalex-snapshot
Diversity, molecular mechanisms and structure-activity relationships of marine protease inhibitors—A review
inferred← citeshttps://doi.org/10.1016/j.phytochem.2009.09.010openalex-snapshot
Tiglicamides A–C, cyclodepsipeptides from the marine cyanobacterium Lyngbya confervoides
inferred← citeshttps://doi.org/10.1016/j.tet.2008.02.035openalex-snapshot
Pompanopeptins A and B, new cyclic peptides from the marine cyanobacterium Lyngbya confervoides
inferred← citeshttps://doi.org/10.1016/j.tet.2019.04.046openalex-snapshot
Kyanamide, a new Ahp-containing depsipeptide from marine cyanobacterium Caldora penicillata
inferred← citeshttps://doi.org/10.1016/j.tetlet.2010.10.062openalex-snapshot
Depsipeptides from a Guamanian marine cyanobacterium, Lyngbya bouillonii, with selective inhibition of serine proteases
inferred← citeshttps://doi.org/10.1016/j.tetlet.2014.05.099openalex-snapshot
Maedamide, a novel chymotrypsin inhibitor from a marine cyanobacterial assemblage of Lyngbya sp.
inferred← citeshttps://doi.org/10.1016/j.tetlet.2016.08.012openalex-snapshot
Urumamide, a novel chymotrypsin inhibitor with a β-amino acid from a marine cyanobacterium Okeania sp.
inferred← citeshttps://doi.org/10.1021/acs.est.5c05763openalex-snapshot
Genetic and Metabolic Diversity of Cyanobacteria on the Rock–Water Interface in Mountainous Ecosystems
inferred← citeshttps://doi.org/10.1021/acs.est.6c07305openalex-snapshot
Dual Roles of Cyanopeptides as Substrates and Inhibitors of Enzymes in Surface Waters
inferred← citeshttps://doi.org/10.1021/acs.jnatprod.2c00782openalex-snapshot
Biosynthesis of Lyngbyastatins 1 and 3, Cytotoxic Depsipeptides from an Okeania sp. Marine Cyanobacterium
inferred← citeshttps://doi.org/10.1021/acs.jnatprod.2c00978openalex-snapshot
Sadopeptins A and B, Sulfoxide- and Piperidone-Containing Cyclic Heptapeptides with Proteasome Inhibitory Activity from a Streptomyces sp.
inferred← citeshttps://doi.org/10.1021/acs.jnatprod.5c01380openalex-snapshot
Native Metabolomics Unveils Suomilide Analogs with Potent Trypsin Inhibitory Activity
inferred← citeshttps://doi.org/10.1021/acs.jnatprod.6c00688openalex-snapshot
Editorial Introducing the Collection in Honor of Valerie J. Paul
inferred← citeshttps://doi.org/10.1021/acs.jnatprod.7b00256openalex-snapshot
Kohamamides A, B, and C, Cyclic Depsipeptides from an Okeania sp. Marine Cyanobacterium
inferred← citeshttps://doi.org/10.1021/acs.jnatprod.8b00117openalex-snapshot
Jizanpeptins, Cyanobacterial Protease Inhibitors from a Symploca sp. Cyanobacterium Collected in the Red Sea
inferred← citeshttps://doi.org/10.1021/acs.jnatprod.9b01019openalex-snapshot
Pagoamide A, a Cyclic Depsipeptide Isolated from a Cultured Marine Chlorophyte, Derbesia sp., Using MS/MS-Based Molecular Networking
inferred← citeshttps://doi.org/10.1021/acschembio.9b00992openalex-snapshot
Tutuilamides A–C: Vinyl-Chloride-Containing Cyclodepsipeptides from Marine Cyanobacteria with Potent Elastase Inhibitory Properties
inferred← citeshttps://doi.org/10.1021/jm3017305openalex-snapshot
Potent Elastase Inhibitors from Cyanobacteria: Structural Basis and Mechanisms Mediating Cytoprotective and Anti-Inflammatory Effects in Bronchial Epithelial Cells
inferred← citeshttps://doi.org/10.1021/jm9009394openalex-snapshot
Grassystatins A−C from Marine Cyanobacteria, Potent Cathepsin E Inhibitors That Reduce Antigen Presentation
inferred← citeshttps://doi.org/10.1021/jo1013564openalex-snapshot
Grassypeptolides A−C, Cytotoxic Bis-thiazoline Containing Marine Cyclodepsipeptides
inferred← citeshttps://doi.org/10.1021/np0702436openalex-snapshot
Lyngbyastatins 5–7, Potent Elastase Inhibitors from Floridian Marine Cyanobacteria, Lyngbya spp.
inferred← citeshttps://doi.org/10.1021/np070280xopenalex-snapshot
Symplocamide A, a Potent Cytotoxin and Chymotrypsin Inhibitor from the Marine Cyanobacterium Symploca sp.
inferred← citeshttps://doi.org/10.1021/np0706769openalex-snapshot
Dragonamides C and D, Linear Lipopeptides from the Marine Cyanobacterium Brown Lyngbya polychroa
inferred← citeshttps://doi.org/10.1021/np200270dopenalex-snapshot
Cyclic Depsipeptides, Grassypeptolides D and E and Ibu-epidemethoxylyngbyastatin 3, from a Red Sea Leptolyngbya Cyanobacterium
inferred← citeshttps://doi.org/10.1021/np300150hopenalex-snapshot
Stigonemapeptin, an Ahp-Containing Depsipeptide with Elastase Inhibitory Activity from the Bloom-Forming Freshwater Cyanobacterium Stigonema sp.
inferred← citeshttps://doi.org/10.1021/np8002172openalex-snapshot
Kempopeptins A and B, Serine Protease Inhibitors with Different Selectivity Profiles from a Marine Cyanobacterium, Lyngbya sp.
inferred← citeshttps://doi.org/10.1021/np900603fopenalex-snapshot
Molassamide, a Depsipeptide Serine Protease Inhibitor from the Marine Cyanobacterium Dichothrix utahensis
inferred← citeshttps://doi.org/10.1021/ol702946dopenalex-snapshot
Total Structure Determination of Grassypeptolide, a New Marine Cyanobacterial Cytotoxin
inferred← citeshttps://doi.org/10.1038/ja.2011.21openalex-snapshot
Cyanobacteria: an emerging source for drug discovery
inferred← citeshttps://doi.org/10.1039/c8np00095fopenalex-snapshot
Built to bind: biosynthetic strategies for the formation of small-molecule protease inhibitors
inferred← citeshttps://doi.org/10.1039/c9np00033jopenalex-snapshot
From dolastatin 13 to cyanopeptolins, micropeptins, and lyngbyastatins: the chemical biology of Ahp-cyclodepsipeptides
inferred← citeshttps://doi.org/10.1039/c9np00060gopenalex-snapshot
Targeting eukaryotic proteases for natural products-based drug development
inferred← citeshttps://doi.org/10.1055/s-0029-1185332openalex-snapshot
Largamides A–C, Tiglic Acid-Containing Cyclodepsipeptides with Elastase-Inhibitory Activity from the Marine CyanobacteriumLyngbya confervoides
inferred← citeshttps://doi.org/10.1080/07391102.2020.1838948openalex-snapshot
The use of cyanobacterial metabolites as natural medical and biotechnological tools: review article
inferred← citeshttps://doi.org/10.1080/07391102.2022.2062051openalex-snapshot
Recent progression of cyanobacteria and their pharmaceutical utility: an update
inferred← citeshttps://doi.org/10.1080/14756366.2021.1960830openalex-snapshot
Cyanobacteria and microalgae bioactive compounds in skin-ageing: potential to restore extracellular matrix filling and overcome hyperpigmentation
inferred← citeshttps://doi.org/10.1111/jpy.13527openalex-snapshot
Occurrence of protease inhibitors in freshwater cyanobacterium Woronichinia naegeliana (Unger) Elenkin
inferred← citeshttps://doi.org/10.1128/aem.02656-08openalex-snapshot
Phylogenetic and Chemical Diversity of Three Chemotypes of Bloom-Forming Lyngbya Species ( Cyanobacteria : Oscillatoriales ) from Reefs of Southeastern Florida
inferred← citeshttps://doi.org/10.1142/s2737416524500133openalex-snapshot
Cyanobacterial Metabolites as Promising Neuroprotective Agents by Targeting Phosphoglycerate Kinase 1: Dynamic In Silico Approaches
inferred← citeshttps://doi.org/10.1246/bcsj.20140008openalex-snapshot
Kurahamide, a Cyclic Depsipeptide Analog of Dolastatin 13 from a Marine Cyanobacterial Assemblage of Lyngbya sp.
inferred← citeshttps://doi.org/10.1248/cpb.56.1191openalex-snapshot
Cyanopeptoline CB071: A Cyclic Depsipeptide Isolated from the Freshwater Cyanobacterium Aphanocapsa sp.
inferred← citeshttps://doi.org/10.2174/138945011798109455openalex-snapshot
Chemodiversity in Freshwater and Terrestrial Cyanobacteria – A Source for Drug Discovery
inferred← citeshttps://doi.org/10.3109/1040841x.2014.957640openalex-snapshot
Recent developments in therapeutic applications of Cyanobacteria
inferred← citeshttps://doi.org/10.3389/fmars.2021.766282openalex-snapshot
Sequestration and Cyanobacterial Diet Preferences in the Opisthobranch Molluscs Dolabrifera nicaraguana and Stylocheilus rickettsi
inferred← citeshttps://doi.org/10.3389/fmicb.2017.00515openalex-snapshot
Uncovering Potential Applications of Cyanobacteria and Algal Metabolites in Biology, Agriculture and Medicine: Current Status and Future Prospects
inferred← citeshttps://doi.org/10.3389/fphar.2020.00688openalex-snapshot
The Natural Polypeptides as Significant Elastase Inhibitors
inferred← citeshttps://doi.org/10.3390/antiox15050615openalex-snapshot
Antioxidant, Anti-Inflammatory and Anticancer Peptides from Extreme Marine Environments
inferred← citeshttps://doi.org/10.3390/hydrobiology1030024openalex-snapshot
Hydrobiological Aspects of Fatty Acids: Unique, Rare, and Unusual Fatty Acids Incorporated into Linear and Cyclic Lipopeptides and Their Biological Activity
inferred← citeshttps://doi.org/10.3390/ijms19030919openalex-snapshot
Therapeutic Properties and Biological Benefits of Marine-Derived Anticancer Peptides
inferred← citeshttps://doi.org/10.3390/ijms23062924openalex-snapshot
Peptide Human Neutrophil Elastase Inhibitors from Natural Sources: An Overview
inferred← citeshttps://doi.org/10.3390/ijms241814035openalex-snapshot
Non-Canonical Amino Acids in Analyses of Protease Structure and Function
inferred← citeshttps://doi.org/10.3390/md10102181openalex-snapshot
Marine Cyanobacteria Compounds with Anticancer Properties: A Review on the Implication of Apoptosis
inferred← citeshttps://doi.org/10.3390/md11051693openalex-snapshot
“Head-to-Side-Chain” Cyclodepsipeptides of Marine Origin
inferred← citeshttps://doi.org/10.3390/md13063892openalex-snapshot
Structural Characterization of New Peptide Variants Produced by Cyanobacteria from the Brazilian Atlantic Coastal Forest Using Liquid Chromatography Coupled to Quadrupole Time-of-Flight Tandem Mass Spectrometry
inferred← citeshttps://doi.org/10.3390/md14050097openalex-snapshot
Tiny Microbes with a Big Impact: The Role of Cyanobacteria and Their Metabolites in Shaping Our Future
inferred← citeshttps://doi.org/10.3390/md15050132openalex-snapshot
New Peptides Isolated from Marine Cyanobacteria, an Overview over the Past Decade
inferred← citeshttps://doi.org/10.3390/md20080466openalex-snapshot
Therapeutic Potential of Marine Peptides in Prostate Cancer: Mechanistic Insights
inferred← citeshttps://doi.org/10.3390/md21020120openalex-snapshot
Marine Organisms as a Prolific Source of Bioactive Depsipeptides
inferred← citeshttps://doi.org/10.3390/md21100508openalex-snapshot
Structural Diversity and Biological Activity of Cyanopeptolins Produced by Nostoc edaphicum CCNP1411
inferred← citeshttps://doi.org/10.3390/md7040528openalex-snapshot
Lyngbyastatins 8–10, Elastase Inhibitors with Cyclic Depsipeptide Scaffolds Isolated from the Marine Cyanobacterium Lyngbya semiplena
inferred← citeshttps://doi.org/10.3390/md8061803openalex-snapshot
Intramolecular Modulation of Serine Protease Inhibitor Activity in a Marine Cyanobacterium with Antifeedant Properties
inferred← citeshttps://doi.org/10.3390/md8061817openalex-snapshot
New Peptides Isolated from Lyngbya Species: A Review
inferred← citeshttps://doi.org/10.3390/molecules25092197openalex-snapshot
Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets
inferred← citeshttps://doi.org/10.3390/molecules26010247openalex-snapshot
Cyanobacteria as Natural Therapeutics and Pharmaceutical Potential: Role in Antitumor Activity and as Nanovectors
inferred← citeshttps://doi.org/10.3390/molecules26051411openalex-snapshot
Thermochemistry of Solution, Solvation, and Hydrogen Bonding of Cyclic Amides in Proton Acceptor and Donor Solvents. Amide Cycle Size Effect
inferred← citeshttps://doi.org/10.3410/f.5811956.5793054openalex-snapshot
Faculty Opinions recommendation of Marine pharmacology in 2007-8: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms…
inferred← citeshttps://doi.org/10.70675/6dd187b1z63a9z4bbaza087zc802ababf919openalex-snapshot
Nouvelle approche du traitement de l’emphysème ;Synthèse et activité biologique d’inhibiteurs de l’élastase neutrophile humaine.
inferred← citeshttps://doi.org/10.9734/jpri/2019/v31i630382openalex-snapshot
Computational Design of New Analogues from Lyngbyastatin-2 against Epidermal Growth Factor Receptor (EGFR) through Molecular Docking
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.